- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05958979
Effects of e-Cigarettes on Perceptions and Behavior - Remote Substudy # 1
July 14, 2023 updated by: Adam Leventhal, University of Southern California
This study assess the ways in which e-cigarette product characteristics, such as marketing strategies, impact user experience to inform potential regulations.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
There are three primary objectives to the study: (1) Determine which dimensions of e-cigarette product diversity differentially affect product appeal in the overall population of tobacco product users as well as affect product appeal across young adult e-cigarette users and middle-age/older adult smokers; (2) Determine which dimensions of e-cigarette product diversity differentially affect product appeal in the overall population of tobacco product users as well as affect abuse liability in young adult e-cigarette users and the ability to resist smoking in adult smokers; (3) Determine the affect of product characteristics on e-cigarette nicotine delivery profile.
Study Type
Interventional
Enrollment (Actual)
601
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90033
- University of Southern California
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
Vapers/E-cigarette Users
- Regular use of e-cigarettes/vaping devices containing nicotine
Cigarette Smokers
- Regular use of cigarettes containing nicotine
Exclusion Criteria:
- Pregnant or planning to become pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: E-cigarette e-liquid 1
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 2
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 3
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 4
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 5
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 6
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 7
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 8
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 9
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 10
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 11
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 12
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 13
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 14
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 15
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 16
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 17
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 18
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 19
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
Experimental: E-cigarette e-liquid 20
|
Participants will self-administer experimenter-provided e-cigarettes
Participants will self-administer experimenter-provided e-cigarettes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subjective Appeal Rating Measure
Time Frame: 1 hour
|
This self-report measures of subjective product appeal will be completed following e-cigarette self-administration and review of marketing strategies.
Scores can range from 0 to 100 for the appeal rating, with lower scores representing lower levels of appeal and higher scores representing higher levels of appeal.
|
1 hour
|
Sensory Attributes
Time Frame: 1 hour
|
Self-report measures of product sensory attributes will be completed following e-cigarette self-administration and review of marketing strategies.
Scores can range from 0 to 100 for the sensory attribute rating, with lower scores representing lower levels of liking the sensory attribute and higher scores representing greater liking of the sensory attribute.
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 25, 2020
Primary Completion (Actual)
May 1, 2022
Study Completion (Actual)
May 1, 2022
Study Registration Dates
First Submitted
July 7, 2023
First Submitted That Met QC Criteria
July 14, 2023
First Posted (Actual)
July 25, 2023
Study Record Updates
Last Update Posted (Actual)
July 25, 2023
Last Update Submitted That Met QC Criteria
July 14, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Substudy #1: UP-20-00744
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Electronic Cigarette Use
-
University of Southern CaliforniaCompletedElectronic Cigarette Use | Cigarette Smoking | Cigarette Use, Electronic | VapingUnited States
-
University of Southern CaliforniaCompletedElectronic Cigarette Use | Cigarette Smoking | Cigarette Use, Electronic | VapingUnited States
-
University of Southern CaliforniaCompletedElectronic Cigarette Use | Cigarette Smoking | Cigarette Use, Electronic | E-Cig UseUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
University of VermontNational Institute on Drug Abuse (NIDA)Completed
-
University of OklahomaNational Institute on Drug Abuse (NIDA); University of Wisconsin, Madison; University... and other collaboratorsRecruiting
-
Virginia Commonwealth UniversityU.S. Department of JusticeRecruitingElectronic Cigarette UseUnited States
-
Eastern Virginia Medical SchoolNational Institute on Drug Abuse (NIDA)Terminated
-
Yale UniversityNational Institute on Drug Abuse (NIDA)WithdrawnElectronic Cigarette UseUnited States
Clinical Trials on Control Marketing Strategies
-
Fred Hutchinson Cancer CenterRecruiting
-
Montreal Heart InstituteCompletedAtrial Fibrillation | Congestive Heart FailureCanada
-
Columbia UniversityCompletedHIV (Human Immunodeficiency Virus)United States
-
Washington University School of MedicineUniversity of Rhode Island; Pwani University; Egerton UniversityActive, not recruitingMalnutrition, Child | Growth; Stunting, NutritionalKenya
-
University of OuluOulu University Hospital; Umeå University; Tampere University; Sonvox ABCompletedFunctional Voice Disorder
-
Tufts UniversityCompleted
-
Health Services Academy, Islamabad, PakistanCompletedHypertension | Hypertensive PatientsPakistan
-
Universiti Putra MalaysiaUnknownType2 Diabetes | Postprandial HyperglycemiaMalaysia
-
Massachusetts General HospitalRecruitingSuicideUnited States
-
HabitAware Inc.University of MinnesotaNot yet recruitingBinge-Eating Disorder